AVE 33.3% 0.2¢ avecho biotechnology limited

Ann: Phosphagenics Expands Licence Agreement for Diclofenac Gel-POH.AX, page-15

  1. 5,322 Posts.
    Why poke the bear Turps? He'll no doubt offer another Zinger in good time.
    What I find interesting is how POHs BDM achieved zip for years and now has kicked 3 big ones for us in as many weeks. Supportive CEO and Board who with extensive experience on the pharma side of the table understand how to get a deal done is my guess. ( with no disrespect to HR and those that travelled before Or maybe luck is shining on POH at last.

    Todays ann looks very strategic for Diclo. Themis gets a weird grapbag of territories leaving all the major regions for......a Novatis deal? The dream for a global TPM product gets real
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.